22/06/2022
Wake up women HRT is a privilege and a must .. are you on it ?
This study was the first of its kind to evaluate the safety and efficacy of compounded bHRT. Although the studies were small, short in duration and did not address sterile products (injectables and pellets), they are very reassuring. The fact that the journal of NAMS, “Menopause” published this analysis itself is an interesting turn of events. The organization and its leaders have been very vocal in its disparagement of compounded therapies.
I suspect that the tide if turning with more and more women and providers joining forces to showcase the long-standing safety and utilization of compounded product which have largely filled a huge void by the commercial sector for women. I hope this is a sign of things to come and that compounded therapies made by reputable and highly regulated compounded pharmacies will get to step into the “sunlight” of patient care.